Previous Close 21.04
Price To book 68.31
Market Cap 6.20B
Short Ratio 3.14
Av. Daily Volume 4,570,950
NewsSee all news
SEC filingsSee all SEC filings
Drug catalyst information is displayed when you hover over the stage bar graph.
Cabozantinib - CABOSUN
First-Line RCC - cancer
XL184 cabozantinib (CELESTIAL)
Advanced hepatocellular cancer (HCC)
- Here's Why the Best Is Yet to Come for Exelixis, Inc.
- ETFs with exposure to Exelixis, Inc. : April 19, 2017
- Exelixis to Release First Quarter 2017 Financial Results on Monday, May 1, 2017
- Exelixis, Inc.: Time to Move On?
- 3 Stocks That Turned $5,000 Into More Than $18,000 in a Year or Less
- Exelixis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- 3 Winning Stocks You Never Saw Coming
- Exelixis Further Reduces Indebtedness by Repaying Silicon Valley Bank Term Loan
- Exelixis to Present at the Needham & Company Healthcare Conference on April 4
- Exelixis, Inc. breached its 50 day moving average in a Bullish Manner : EXEL-US : March 27, 2017
- When Profit Makers Can Be Active Profit Takers
- Why Exelixis Is Already Up 55% This Year
- The 3 Most Important Numbers for Exelixis, Inc.
- Top Stocks That Are Already Crushing the Market in 2017
- 3 Horrible Stocks for Retirees
- Is Exelixis' Balance Sheet Safe?
- 3 Factors That Drove Exelixis, Inc. Higher By 19% in February
- ETFs with exposure to Exelixis, Inc. : March 6, 2017
- DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material 17759342
- DEF 14A - Other definitive proxy statements 17759338
- CT ORDER - Confidential treatment order 17661868
- CT ORDER - Confidential treatment order 17661757
- CT ORDER - Confidential treatment order 17661653
- 10-K - Annual report (Section 13 and 15(d), not S-K Item 405) 17641799
- 8-K - Current report 17641757
- SC 13G/A (Amend) - Statement of acquisition of beneficial ownership by individuals 17612539
- SC 13G/A (Amend) - Statement of acquisition of beneficial ownership by individuals 17604563
- SC 13G/A (Amend) - Statement of acquisition of beneficial ownership by individuals 17587427